CPT 93923: Noninvasive Arterial Evaluation for Extremities
Medicare pays $93 and commercial payers pay $223 on average nationally for this procedure.
CPT code 93923 describes noninvasive arterial diagnostic procedures used to evaluate blood flow and detect arterial blockages in the upper and/or lower extremities, commonly performed as plethysmography, segmental blood pressure measurements, and Doppler waveform analysis; service type: vascular diagnostic testing; typical site of service: outpatient vascular laboratory, hospital outpatient department, or ambulatory diagnostic center.
For related coverage guidance, see recent payer policy updates: Cardiac Computed Tomography (CCT)/Coronary Computed Tomographic Angiography (CCTA), Cardiovascular Disease Risk Assessment, Biomarkers for Myocardial Infarction and Chronic Heart Failure.
Customize your policy alerts
Sign up for cpt 93923 policy alerts
Get alerted when payer policies referencing 93923 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Nationally, Medicare averages $92.8 for CPT 93923 while BUCA’s commercial mean is $222.7, indicating BUCA pays roughly $130 more on average than Medicare for this service. Blue Cross Blue Shield sits near the high end of commercial means at $289.8, with Cigna and UnitedHealth Group closer to BUCA’s average, and Aetna a step below those peers.
Dispersion measured by the interquartile range (P75−P25) is widest for Blue Cross Blue Shield at $125 (from $220.1 to $326.5) and much narrower for Aetna at $118.9 (from $36.9 to $155.6) and Cigna at $144.1 (from $47.2 to $209.3). UnitedHealth Group’s IQR is $152.1 (from $53.9 to $206.8), while BUCA’s IQR is $123.3 (from $145.5 to $268.3); Medicare’s IQR is $111 (from $22 to $133).